Last reviewed · How we verify
Tiger Balm — Competitive Intelligence Brief
marketed
Topical counter-irritant / rubefacient
TRPM8, TRPA1 (transient receptor potential channels)
Pain Management / Musculoskeletal
Small molecule
Live · refreshed every 30 min
Target snapshot
Tiger Balm (Tiger Balm) — Apothyx, Co.. Tiger Balm provides topical pain relief and warming sensation through a combination of menthol, camphor, and other essential oils that stimulate sensory receptors and increase local blood flow.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tiger Balm TARGET | Tiger Balm | Apothyx, Co. | marketed | Topical counter-irritant / rubefacient | TRPM8, TRPA1 (transient receptor potential channels) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical counter-irritant / rubefacient class)
- Apothyx, Co. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tiger Balm CI watch — RSS
- Tiger Balm CI watch — Atom
- Tiger Balm CI watch — JSON
- Tiger Balm alone — RSS
- Whole Topical counter-irritant / rubefacient class — RSS
Cite this brief
Drug Landscape (2026). Tiger Balm — Competitive Intelligence Brief. https://druglandscape.com/ci/tiger-balm. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab